• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[低分子量和高分子量右旋糖酐对选定血清脂质参数的影响。1]

[Effect of low and high molecular weight dextrans on selected serum lipid parameters. 1].

作者信息

Rühlmann C, Koksch M, Kuklinski B

机构信息

Abteilung Kardiologie/Angiologie, Universität Leipzig.

出版信息

Z Gesamte Inn Med. 1992 Jan;47(1):6-11.

PMID:1373926
Abstract

Three male patients with hyperlipidaemia were given daily infusions of dextran over a period of 10 days. Plasma levels of total cholesterol, LDL and HDL cholesterol, apolipoprotein B and AI and triglycerides were analysed after the infusion of dextrans different in dose and molecular size. Dextrans caused alterations of some plasma lipids and lipoproteins exceeding the haemodilution effect. The degree of lipid lowering depends on the volume and molecular size of the administered dextran.

摘要

三名高脂血症男性患者在10天内每日输注右旋糖酐。在输注不同剂量和分子大小的右旋糖酐后,分析了血浆总胆固醇、低密度脂蛋白和高密度脂蛋白胆固醇、载脂蛋白B和AI以及甘油三酯的水平。右旋糖酐引起的一些血浆脂质和脂蛋白的改变超过了血液稀释效应。降脂程度取决于所给予右旋糖酐的体积和分子大小。

相似文献

1
[Effect of low and high molecular weight dextrans on selected serum lipid parameters. 1].[低分子量和高分子量右旋糖酐对选定血清脂质参数的影响。1]
Z Gesamte Inn Med. 1992 Jan;47(1):6-11.
2
[The effect of low and high molecular weight dextrans on selected serum lipid parameters. 2].[低分子量和高分子量右旋糖酐对选定血清脂质参数的影响。2]
Z Gesamte Inn Med. 1992 Aug;47(8):337-40.
3
[The effect of low and high molecular weight dextrans on selected lipid parameters in serum. Part 3].[低分子量和高分子量右旋糖酐对血清中选定脂质参数的影响。第3部分]
Z Gesamte Inn Med. 1993 Aug;48(8):381-5.
4
[Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
Vasa Suppl. 1991;32:342-4.
5
[Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].[外周动脉闭塞性疾病中的血液稀释——比较三种不同血液稀释变体的研究]
Vasa Suppl. 1990;30:137-8.
6
[Effect of adjuvant infusion therapy of low molecular weight dextrans (Infukoll M 40) and deproteinized hemoderivate (Actovegin) in Fontaine stage IV chronic arterial occlusive diseases].
Zentralbl Chir. 1988;113(16):1044-55.
7
[Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Acta Med Austriaca. 1991;18 Suppl 1:23-7.
8
[Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
Acta Med Austriaca. 1991;18 Suppl 1:45-7.
9
[Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
Acta Med Austriaca. 1991;18 Suppl 1:20-2.
10
[Effect of hydroxyethyl starch and dextran on metabolism of extremity muscles in patients with arterial occlusive disease].
Vasa Suppl. 1991;33:171.